BACKGROUND: Injecting drug users (IDU) have a key role in Hepatitis C Virus (HCV) epidemiology. Young/short-term IDUs constitute a target group for preventive/harm reduction interventions. OBJECTIVES: To investigate HCV transmission among young/short-term (ST) and long-term (LT) IDUs, from the perspective of epidemiology and molecular biology. STUDY DESIGN: Cross-sectional study assessing the prevalence of HCV infection/genotypes, as well as risk behaviours/practices among IDUs from Rio de Janeiro. Phylogenetic analyses were performed and the extent of segregation between sequences was quantified by the Association Index. RESULTS: ST were more likely to engage into needle-sharing (p=.021) and LT to attend Needle Exchange Programs (p=.006). HCV prevalence was 10.1% vs. 23.4% among initiates and LT, respectively (p<.001). Older age vs. imprisonment and longer duration of IDU career were independent predictors for HCV infection among ST and LT, respectively. Among the latter, NEP attendance was inversely associated with viral infection. HCV3a infections were the most prevalent. A moderate extent of phylogenetic segregation between sequences was found, suggestive of transmission between IDU subgroups. CONCLUSIONS: The lower HCV prevalence among young/short-term IDUs cannot be viewed with complacency, due to their frequent engagement into direct/indirect sharing practices and the ongoing transmission between IDU subsets. To avert new infections, preventive/harm reduction policies must be tailored to empirical findings.
BACKGROUND: Injecting drug users (IDU) have a key role in Hepatitis C Virus (HCV) epidemiology. Young/short-term IDUs constitute a target group for preventive/harm reduction interventions. OBJECTIVES: To investigate HCV transmission among young/short-term (ST) and long-term (LT) IDUs, from the perspective of epidemiology and molecular biology. STUDY DESIGN: Cross-sectional study assessing the prevalence of HCV infection/genotypes, as well as risk behaviours/practices among IDUs from Rio de Janeiro. Phylogenetic analyses were performed and the extent of segregation between sequences was quantified by the Association Index. RESULTS: ST were more likely to engage into needle-sharing (p=.021) and LT to attend Needle Exchange Programs (p=.006). HCV prevalence was 10.1% vs. 23.4% among initiates and LT, respectively (p<.001). Older age vs. imprisonment and longer duration of IDU career were independent predictors for HCV infection among ST and LT, respectively. Among the latter, NEP attendance was inversely associated with viral infection. HCV3a infections were the most prevalent. A moderate extent of phylogenetic segregation between sequences was found, suggestive of transmission between IDU subgroups. CONCLUSIONS: The lower HCV prevalence among young/short-term IDUs cannot be viewed with complacency, due to their frequent engagement into direct/indirect sharing practices and the ongoing transmission between IDU subsets. To avert new infections, preventive/harm reduction policies must be tailored to empirical findings.
Authors: Joanne Csete; Adeeba Kamarulzaman; Michel Kazatchkine; Frederick Altice; Marek Balicki; Julia Buxton; Javier Cepeda; Megan Comfort; Eric Goosby; João Goulão; Carl Hart; Thomas Kerr; Alejandro Madrazo Lajous; Stephen Lewis; Natasha Martin; Daniel Mejía; Adriana Camacho; David Mathieson; Isidore Obot; Adeolu Ogunrombi; Susan Sherman; Jack Stone; Nandini Vallath; Peter Vickerman; Tomáš Zábranský; Chris Beyrer Journal: Lancet Date: 2016-03-24 Impact factor: 79.321
Authors: A F Poon; J Grebely; B Jacka; T Applegate; M Krajden; A Olmstead; P R Harrigan; Bdl Marshall; K DeBeck; M-J Milloy; F Lamoury; O G Pybus; V D Lima; G Magiorkinis; V Montoya; J Montaner; J Joy; C Woods; S Dobrer; G J Dore Journal: Hepatology Date: 2014-09-29 Impact factor: 17.425
Authors: Nara R Freitas; Sheila A Teles; Marcos A Matos; Carmen Lr Lopes; Nádia Rs Reis; Márcia P Espírito-Santo; Elisabeth Lampe; Regina Mb Martins Journal: Virol J Date: 2010-08-27 Impact factor: 4.099
Authors: Axel Danielsson; Navaneethan Palanisamy; Sultan Golbob; Hong Yin; Jonas Blomberg; Johan Hedlund; Staffan Sylvan; Johan Lennerstrand Journal: Infect Ecol Epidemiol Date: 2014-01-15
Authors: Anna L McNaughton; Iain Dugald Cameron; Elizabeth B Wignall-Fleming; Roman Biek; John McLauchlan; Rory N Gunson; Kate Templeton; Harriet Mei-Lin Tan; E Carol McWilliam Leitch Journal: J Virol Date: 2015-08-26 Impact factor: 5.103
Authors: Leila M M B Pereira; Celina M T Martelli; Regina C Moreira; Edgar Merchan-Hamman; Airton T Stein; Maria Regina A Cardoso; Gerusa M Figueiredo; Ulisses R Montarroyos; Cynthia Braga; Marília D Turchi; Gabriela Coral; Deborah Crespo; Maria Luiza C Lima; Luis Claudio A Alencar; Marcelo Costa; Alex A dos Santos; Ricardo A A Ximenes Journal: BMC Infect Dis Date: 2013-02-01 Impact factor: 3.090
Authors: Anna S Nishiya; Cesar de Almeida-Neto; Suzete C Ferreira; Cecília S Alencar; Claudia Di-Lorenzo-Oliveira; José E Levi; Nanci A Salles; Alfredo Mendrone; Ester C Sabino Journal: PLoS One Date: 2014-01-21 Impact factor: 3.240